VAXCYTE INC (PCVX)
US92243G1085 - Common Stock
| TTM (2024-9-30) | 2023 (2023-12-31) | 2022 (2022-12-31) | 2021 (2021-12-31) | 2020 (2020-12-31) | ||||
|---|---|---|---|---|---|---|---|---|
| CASH FLOWS FROM OPERATING ACTIVITIES | ||||||||
| Net Income | -507.65M | -402.27M | -223.49M | -100.08M | -89.22M | |||
| Depreciation Amortization | 5.03M | 3.16M | 2.58M | 1.80M | 1.41M | |||
| Change In Working Capital | -14.35M | 81.32M | 12.74M | -37.01M | 35.27M | |||
| Interest Paid | N/A | 0.00 | 0.00 | 10.00K | 10.00K | |||
| Other non cash items | 46.93M | 21.00M | 37.57M | 13.89M | 5.91M | |||
| OPERATING CASH FLOW | -470.04M | -296.79M | -170.60M | -121.39M | -46.63M | |||
| CASH FLOWS FROM INVESTING ACTIVITIES | ||||||||
| Capital Expenditure | -146.20M | -67.88M | -5.85M | -6.56M | -1.16M | |||
| Other Investing Activity | -1.32B | -705.43M | 80.43M | -205.75M | 50.00K | |||
| INVESTING CASH FLOW | -1.46B | -773.31M | 74.59M | -212.31M | -1.11M | |||
| CASH FLOWS FROM FINANCING ACTIVITIES | ||||||||
| Debt Issued/Reduced | N/A | N/A | 0.00 | 0.00 | -60.00K | |||
| Stock Issued/Repurchased | 765.47M | 643.69M | 862.41M | 17.80M | 378.30M | |||
| Other Financing Activity | 1.68B | -3.88M | -860.00K | 0.00 | -3.37M | |||
| FINANCING CASH FLOW | 2.45B | 639.81M | 861.55M | 17.80M | 374.87M | |||
| Exchange Rate Effect | -8.61M | -6.69M | 140.00K | -440.00K | 90.00K | |||
| CHANGE IN CASH | 505.27M | -436.97M | 765.68M | -316.34M | 327.22M | |||
| FREE CASH FLOW | ||||||||
| Operating Cash Flow | -470.04M | -296.79M | -170.60M | -121.39M | -46.63M | |||
| Capital Expenditure | -146.20M | -67.88M | -5.85M | -6.56M | -1.16M | |||
| FREE CASH FLOW | -616.24M | -364.67M | -176.45M | -127.95M | -47.79M | |||
All data in USD